Further research measuring glycemia and insulin dynamics beyond TB treatment is ultimately needed to determine if the post-TB DM phenotype is more akin to gestational diabetes [34] or if those patients carry a different risk of developing relapse of TB disease [35, 36]. The gene discussed is INS; the disease is tuberculosis.